Kärcher, A., Isigkeit, L., Bandomir, N. C., Schubert-Zsilavecz, M., Heitel, P. (2026). The metabolic dysfunction-associated steatohepatitis (MASH) drug resmetirom exhibits broad nuclear receptor activity with minimal functional impact. Scientific Reports. https://doi.org/10.1038/s41598-026-37494-y